Cargando…

Improved Differential Diagnosis of Alzheimer’s Disease by Integrating ELISA and Mass Spectrometry-Based Cerebrospinal Fluid Biomarkers

BACKGROUND: Alzheimer’s disease (AD) is diagnosed based on a clinical evaluation as well as analyses of classical biomarkers: Aβ(42), total tau (t-tau), and phosphorylated tau (p-tau) in cerebrospinal fluid (CSF). Although the sensitivities and specificities of the classical biomarkers are fairly go...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khoonsari, Payam Emami, Shevchenko, Ganna, Herman, Stephanie, Remnestål, Julia, Giedraitis, Vilmantas, Brundin, RoseMarie, Degerman Gunnarsson, Malin, Kilander, Lena, Zetterberg, Henrik, Nilsson, Peter, Lannfelt, Lars, Ingelsson, Martin, Kultima, Kim
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6398544/ https://www.ncbi.nlm.nih.gov/pubmed/30614806 http://dx.doi.org/10.3233/JAD-180855

Ejemplares similares

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease
por: Khoonsari, Payam Emami, et al.
Publicado: (2016)

High tau levels in cerebrospinal fluid predict nursing home placement and rapid progression in Alzheimer’s disease
por: Degerman Gunnarsson, Malin, et al.
Publicado: (2016)

Mutation analysis of disease causing genes in patients with early onset or familial forms of Alzheimer’s disease and frontotemporal dementia
por: Pagnon de la Vega, María, et al.
Publicado: (2022)

Increased Release of Apolipoprotein E in Extracellular Vesicles Following Amyloid-β Protofibril Exposure of Neuroglial Co-Cultures
por: Nikitidou, Elisabeth, et al.
Publicado: (2017)

Different Inflammatory Signatures in Alzheimer’s Disease and Frontotemporal Dementia Cerebrospinal Fluid
por: Boström, Gustaf, et al.
Publicado: (2021)

Metabolic drift in the aging nervous system is reflected in human cerebrospinal fluid
por: Peters, Kristian, et al.
Publicado: (2021)

Mixed Pathologies in a Subject with a Novel PSEN1 G206R Mutation
por: Libard, Sylwia, et al.
Publicado: (2022)

Alterations in the tyrosine and phenylalanine pathways revealed by biochemical profiling in cerebrospinal fluid of Huntington’s disease subjects
por: Herman, Stephanie, et al.
Publicado: (2019)

CSF profiling of the human brain enriched proteome reveals associations of neuromodulin and neurogranin to Alzheimer's disease
por: Remnestål, Julia, et al.
Publicado: (2016)

Cognitive function in very old men does not correlate to biomarkers of Alzheimer’s disease
por: Velickaite, V., et al.
Publicado: (2017)

Dual-Task Performance and Neurodegeneration: Correlations Between Timed Up-and-Go Dual-Task Test Outcomes and Alzheimer’s Disease Cerebrospinal Fluid Biomarkers
por: Åhman, Hanna Bozkurt, et al.
Publicado: (2019)

Targeted metabolomics of CSF in healthy individuals and patients with secondary progressive multiple sclerosis using high-resolution mass spectrometry
por: Carlsson, Henrik, et al.
Publicado: (2020)

Altered levels of CSF proteins in patients with FTD, presymptomatic mutation carriers and non-carriers
por: Remnestål, Julia, et al.
Publicado: (2020)

Mass spectrometry based metabolomics for in vitro systems pharmacology: pitfalls, challenges, and computational solutions
por: Herman, Stephanie, et al.
Publicado: (2017)

Integration of magnetic resonance imaging and protein and metabolite CSF measurements to enable early diagnosis of secondary progressive multiple sclerosis
por: Herman, Stephanie, et al.
Publicado: (2018)

Re-Evaluation of Clinical Dementia Diagnoses with Pittsburgh Compound B Positron Emission Tomography
por: Degerman Gunnarsson, M., et al.
Publicado: (2013)

Container-based bioinformatics with Pachyderm
por: Novella, Jon Ander, et al.
Publicado: (2019)

Disease phenotype prediction in multiple sclerosis
por: Herman, Stephanie, et al.
Publicado: (2023)

Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease
por: Bergström, Sofia, et al.
Publicado: (2021)

Dual-task tests discriminate between dementia, mild cognitive impairment, subjective cognitive impairment, and healthy controls – a cross-sectional cohort study
por: Åhman, Hanna B., et al.
Publicado: (2020)

Dual-Task Tests Predict Conversion to Dementia—A Prospective Memory-Clinic-Based Cohort Study
por: B Åhman, Hanna, et al.
Publicado: (2020)

Circulating immune complexes of Aβ and IgM in plasma of patients with Alzheimer’s disease
por: Marcello, Andrea, et al.
Publicado: (2009)

Mosaic Loss of Chromosome Y in Blood Is Associated with Alzheimer Disease
por: Dumanski, Jan P., et al.
Publicado: (2016)

Autologous hematopoietic stem cell transplantation significantly alters circulating ceramides in peripheral blood of relapsing-remitting multiple sclerosis patients
por: Vaivade, Aina, et al.
Publicado: (2023)

Integration of small RNAs from plasma and cerebrospinal fluid for classification of multiple sclerosis
por: Needhamsen, Maria, et al.
Publicado: (2022)

Protein Biomarkers for Insulin Resistance and Type 2 Diabetes Risk in Two Large Community Cohorts
por: Nowak, Christoph, et al.
Publicado: (2016)

Levels of inflammatory cytokines MCP-1, CCL4, and PD-L1 in CSF differentiate idiopathic normal pressure hydrocephalus from neurodegenerative diseases
por: Braun, Madelene, et al.
Publicado: (2023)

Longitudinal changes in the frequency of mosaic chromosome Y loss in peripheral blood cells of aging men varies profoundly between individuals
por: Danielsson, Marcus, et al.
Publicado: (2019)

The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer’s disease
por: Mäkitalo, Signar, et al.
Publicado: (2015)

Increased Number of Plasma B Cells Producing Autoantibodies Against Aβ(42) Protofibrils in Alzheimer’s Disease
por: Söllvander, Sofia, et al.
Publicado: (2015)

Decreased Proportion of Cytomegalovirus Specific CD8 T-Cells but No Signs of General Immunosenescence in Alzheimer’s Disease
por: Westman, Gabriel, et al.
Publicado: (2013)

Biochemical Differences in Cerebrospinal Fluid between Secondary Progressive and Relapsing–Remitting Multiple Sclerosis
por: Herman, Stephanie, et al.
Publicado: (2019)

CRISPR/Cas9 Mediated Disruption of the Swedish APP Allele as a Therapeutic Approach for Early-Onset Alzheimer’s Disease
por: György, Bence, et al.
Publicado: (2018)

The metabolites urobilin and sphingomyelin (30:1) are associated with incident heart failure in the general population
por: Stenemo, Markus, et al.
Publicado: (2019)

Inhibition of mPGES-1 or COX-2 Results in Different Proteomic and Lipidomic Profiles in A549 Lung Cancer Cells
por: Bergqvist, Filip, et al.
Publicado: (2019)

Metabolomics of Cerebrospinal Fluid from Healthy Subjects Reveal Metabolites Associated with Ageing
por: Carlsson, Henrik, et al.
Publicado: (2021)

Further analysis of previously implicated linkage regions for Alzheimer's disease in affected relative pairs
por: Blom, Elin S, et al.
Publicado: (2009)

Timed Up-and-Go Dual-Task Testing in the Assessment of Cognitive Function: A Mixed Methods Observational Study for Development of the UDDGait Protocol
por: Cedervall, Ylva, et al.
Publicado: (2020)

Glucose challenge metabolomics implicates medium-chain acylcarnitines in insulin resistance
por: Nowak, Christoph, et al.
Publicado: (2018)

Methodological Aspects of ELISA Analysis of Thioredoxin 1 in Human Plasma and Cerebrospinal Fluid
por: Lundberg, Mathias, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_cne7prn8g18f7m4os1ffqq08ss